James E. Burke
When Burke took over Johnson & Johnson, the company had thousands of products including Tylenol, which had a 35% share of the analgesic market. Two incidents of cyanide-laced Tylenol capsules dropped Tylenol’s market share to 7%. Burke’s dramatic and swift actions resulted in Tylenol regaining its 35% market share. While leading Johnson & Johnson, Burke also invested in new products such as Retin-A and disposable contact lenses.